EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endoscopic ultrasound-guided radiofrequency ablation for treatment of pancreatic neuroendocrine tumors: Multicenter prospective study

Gianenrico Rizzatti, Bertrand Napoléon iD, Fabrice Caillol iD, Stefano Francesco Crinó iD, Germana de Nucci iD, Khanh Do-Cong Pham, Marc Giovannini, Sarah Leblanc, Silvia Della Torre, Laurent Palazzo, Pia Clara Pafundi, Maria Cristina Conti Bellocchi und 2 weitere

Endoscopy International Open · 16.10.2025 · 13 (CP)

DOI: 10.1055/a-2689-5949 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 16.10.2025. Verfasst von Gianenrico Rizzatti und 13 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Neuroendocrine Tumor Society, Associazione Italiana Ricerca sul Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) has been proposed as a minimally invasive alternative to surgery for treatment of both functional (F-) and non-functional (NF-) pancreatic neuroendocrine tumors (PanNETs). We performed a large prospective multicenter study to evaluate safety and effectiveness of EUS-RFA in patients with F- and NF-PanNETs. Patients with F- (≤ 2 cm) and NF-PanNETs (15 mm-25 mm) were prospectively enrolled over a 43-month period. The primary aim was safety, defined as rate of adverse events (AEs). The secondary aim was effectiveness defined as complete disappearance of the hormonal secretion syndrome in F- PanNETs, whereas for NF-PanNETs, complete response was defined as absence of enhancing tissue and of detectable lesion at magnetic resonance imaging/computed tomography scan and Gallium-positron emission tomography, respectively. The EUSRA 19G needle was used in all patients. After treatment completion, follow-up was performed for 1 year. During the study period, a total of 60 patients were enrolled, 30 with insulinomas and 30 with NF-PanNETs (mean lesion size 14.5 ± 4.5 mm). In 78.3% of patients, a single RFA session was performed. Overall, AEs occurred in nine of 60 patients (15%), in four patients (13.3%) with insulinomas and in five (16.7%) with NF-PanNETs, with only one severe AE. Complete insulin hypersecretion symptom resolution was obtained in 29 of 30 patients (96.7%) with insulinomas, whereas for NF-PanNETs, complete radiological response was obtained in 22 of 25 patients (88%) with long-term follow up. Our prospective international multicenter study demonstrated that EUS-RFA is highly safe and effective for the treatment for both F- and NF-PanNETs.

Schlagwörter

Stichwörter der Autor:innen

Endoscopic ultrasonographyEndoscopy Upper GI TractIntervention EUSPancreasRFA and ablative methods

Autor:innen und Institutionen

  • Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.
  • Endoscopy Unit, Hopital Prive Jean Mermoz, Lyon, France.
  • Endoscopy Unit, Paoli Calmettes Institute, Marseille, France.
  • Gastroenterology and Digestive Endoscopy Unit, University of Verona, Verona, Italy.
  • Gastroenterology and Endoscopy Unit, ASST Rhodense, Garbagnate Milanese, Italy.
  • Medicine, Haukeland University Hospital, Bergen, Norway.

ORCID-Profile: Bertrand Napoléon, Fabrice Caillol, Stefano Francesco Crinó, Germana de Nucci

Förderung

  • European Neuroendocrine Tumor Society
  • Associazione Italiana Ricerca sul Cancro

Zitieren

APA

Rizzatti, G., Napoléon, B., Caillol, F., Crinó, S. F., de Nucci, G., Pham, K. D., Giovannini, M., Leblanc, S., Della Torre, S., Palazzo, L., Pafundi, P. C., Conti Bellocchi, M. C., Spada, C., & Larghi, A. (2025). Endoscopic ultrasound-guided radiofrequency ablation for treatment of pancreatic neuroendocrine tumors: Multicenter prospective study. Endoscopy International Open, 13(CP). https://doi.org/10.1055/a-2689-5949

Vancouver

Rizzatti G, Napoléon B, Caillol F, Crinó SF, de Nucci G, Pham KD, et al. Endoscopic ultrasound-guided radiofrequency ablation for treatment of pancreatic neuroendocrine tumors: Multicenter prospective study. Endoscopy International Open. 2025;13(CP). doi:10.1055/a-2689-5949

BibTeX
@article{Rizzatti2025,
  author = {Rizzatti, Gianenrico and Napoléon, Bertrand and Caillol, Fabrice and Crinó, Stefano Francesco and de Nucci, Germana and Pham, Khanh Do-Cong and Giovannini, Marc and Leblanc, Sarah and Della Torre, Silvia and Palazzo, Laurent and Pafundi, Pia Clara and Conti Bellocchi, Maria Cristina and Spada, Cristiano and Larghi, Alberto},
  title = {Endoscopic ultrasound-guided radiofrequency ablation for treatment of pancreatic neuroendocrine tumors: Multicenter prospective study},
  journal = {Endoscopy International Open},
  year = {2025},
  volume = {13},
  number = {CP},
  doi = {10.1055/a-2689-5949}
}
Kostenlos starten →